Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/13/09 → 04/27/12 |
Funding
- Johnson and Johnson Pharm Research and Dev LLC: $26,276.00
A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects With a Recent Acute Coronary Syndrome
- Lawson, William (CoPI)
- Jeremias, Allen (PI)
- Brown, David (CoPI)
- Chernilas, Joseph (CoPI)
- Gruberg, Luis (CoPI)
- Mani, Anil (CoPI)
Project: Research